The meeting from the International Association for the Study of Lung Cancer (IASLC) is expected to draw 6,500 delegates from more than 100 countries to Melbourne Convention and Exhibition Centre (MCEC).
The event will explore the latest research and treatment for lung cancer, in the pursuit of finding a cure for the disease and improving patient care in the meantime.
“Hosting the World Conference on Lung Cancer in Melbourne highlights Australia’s dedication to world-class research, early detection and equitable care,” said Cancer Council Australia’s CEO, Professor Dorothy Keefe.
“This news, after the 2025 launch of [the] National Lung Cancer Screening Program – a key initiative of the Australian Cancer Plan – showcases our leadership in lung cancer care and sets the stage for global collaboration to bring us closer to a future where fewer people develop lung cancer and more people survive it.”
The event was won by Melbourne Convention Bureau in collaboration with Cancer Council Victoria and has support from both the Victorian state government and Australia’s national business events subvention fund, managed by Tourism Australia.
The CEO of IASLC, Dr Karen Kelly, said Melbourne went above and beyond the significant requirements to host the conference.
“The site-selection process for WCLC is rigorous, ensuring each host city can support a world-class scientific program, foster meaningful multidisciplinary collaboration and create opportunities for our international community to connect,” said Kelly.
“Melbourne not only meets these criteria but exceeds them.
“Australia is a leader in tobacco control and early detection and screening for lung cancer and is home to internationally recognised leaders and programs across the thoracic oncology continuum.
“We look forward to working closely with the Melbourne community to deliver an exceptional four-day conference experience.”
